Skip Navigation

Profile

Edward A. Levine, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

302 Ratings
31 Comments
 

Edward A. Levine, M.D.

Core Director,
Director-At-Large,
Surgical Sciences-Oncology
Professor, Surgical Sciences-Oncology

Clinical Interests

Sarcoma, Gastrointestinal Tumors, Esophageal Cancer, Mesothelioma, Peritoneal Carcinomatosis, Esophageal Tumors, Melanoma, Breast Cancer

Contact Information

Returning Patient Appointments: 336-716-4276
Department: 336-716-0545

Email: elevine@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • B.S., Northern Illinois University, 1981
  • M.D., Finch University of Health Sci/Chicago Med School, 1985
  • Residency, Surgery, Michael Reese Hosp/Med Ctr, 1990
  • Residency, Oncology, U Illinois Hospital, 1992

Board Certifications

  • American Board of Surgery, Surgery

Memberships

  • Nat'L Surgical Adjuvant For Br
  • North Carolina Medical Society
  • Soc Of Surg Of Alimentary Trac
  • Southern Assn For Oncology
  • Southern Medical Association
  • Southern Surgical Assn
  • Southern Surgical Congress
  • Winston-Salem Surgical Society
  • Am Hepato-Pancreato-Biliary
  • Am Coll Of Surgeons
  • Assn Of Academic Surgery
  • Connective Tissue Oncology Soc
  • Alpha Omega Alpha

NPI Number

  • 1275518334
Edward A. Levine, M.D.

Doctor Rating

4.7 out of 5

302 Ratings
31 Comments
 

Edward A. Levine, M.D.

Core Director, Comprehensive Cancer Center
Director-At-Large, Comprehensive Cancer Center
Surgical Sciences-Oncology
Professor, Surgical Sciences-Oncology
Office of Women in Medicine and Science

Research Interests

Peritoneal Neoplasms; Hyperthermia, Induced; Chemotherapy, Cancer, Regional Perfusion; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols
More »

Contact Information

Academic: 336-716-0545 | Department: 336-716-0545

Email: elevine@wakehealth.edu

Media Medical Expert »

Recent Publications

Curative surgical resection of adrenocortical carcinoma: determining long-term outcome based on conditional disease-free probability. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N,.. Ann Surg. 2017;265(1):197-204.

Minimally invasive resection of adrenocortical carcinoma: a multi-institutional study of 201 patients. Lee CW, Salem AI, Schneider DF, Leverson GE, Tran TB, Poultsides GA, Postlewait LM, Maithel SK, Wang TS, Hatzaras I, Shenoy R, Phay JE, Shirley L, Fields RC, Jin LX, Pawlik TM, Prescott JD, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY,.. J Gastrointest Surg. 2017;21(2):352-362.

Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI.. Ann Surg Oncol. 2017;24(4):890-897.

Phase II randomized trial of negative pressure wound therapy to decrease surgical site infection in patients undergoing laparotomy for gastrointestinal, pancreatic, and peritoneal surface malignancies. Shen P, Blackham A, Lewis S, Clark C, Howerton R, Mogal H, Dodson R, Russell GB, Levine EA.. J Am Coll Surg. 2017;224(4):726-737.

Concordance between patient and provider understanding of intent and nature of treatment [abstract]. Duckworth K, Morrell R, Russell G, Canzona M, Powell B, Levine E, Blackstock W, Streer N, Riffle O, McQuellon R.. Psychooncology. 2017;26(Suppl 1):52.

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages. Yang M, Topaloglu U, Petty WJ, Pagni M, Foley KL, Grant SC, Robinson M, Bitting RL, Thomas A, Alistar AT, Desnoyers RJ, Goodman M, Albright C, Porosnicu M, Vatca M, Qasem SA, DeYoung B, Kytola V, Nykter M, Chen K, Levine EA, Staren ED,.. J Hematol Oncol. 2017;10(1):100.

Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? Results of an International Multicenter study. Schwarz L, Votanopoulos K, Morris D, Yonemura Y, Deraco M, Piso P, Moran B, Levine EA, Tuech JJ.. Ann Surg. 2016;263(2):369-375.

Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Doud AN, Levine EA, Fino NF, Stewart JH, Shen P, Votanopoulos KI.. Ann Surg Oncol. 2016;23(2):503-510.

Conditional survival after cytoreductive surgery with heated intraperitoneal chemotherapy for low- and high-grade appendiceal primaries. Mogal HD, Levine EA, Russell G, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2016;23(2):534-538.

To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer. Tran TB, Worhunsky DJ, Squires MH, Jin LX, Spolverato G, Votanopoulos KI, Cho CS, Weber SM, Schmidt C, Levine EA, Bloomston M, Fields RC, Pawlik TM, Maithel SK, Norton JA, Poultsides GA.. Gastric Cancer. 2016;19(3):994-1001.

Is linitis plastica a contraindication for surgical resection: a multi-institution study of the U.S. Gastric Cancer Collaborative. Blackham AU, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI.. Ann Surg Oncol. 2016;23(4):1203-1211.

Nomograms to predict recurrence-free and overall survival after curative resection of adrenocortical carcinoma. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N,.. JAMA Surg. 2016;151(4):365-373.

Incidence of perioperative complications following resection of adrenocortical carcinoma and its association with long-term survival. Margonis GA, Amini N, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Moses LE, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC,.. World J Surg. 2016;40(3):706-714.

Routine admission to intensive care unit after cytoreductive surgery and heated intraperitoneal chemotherapy: not always a requirement. Mogal HD, Levine EA, Fino NF, Obiora C, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2016;23(5):1486-1495.

Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes. Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC,.. Ann Surg Oncol. 2016;23(1):134-141.

Outcomes after resection of cortisol-secreting adrenocortical carcinoma. Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM,.. Am J Surg. 2016;211(6):1106-1113.

Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group. Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM,.. J Am Coll Surg. 2016;222(4):480-490.

Curative resection of adrenocortical carcinoma: rates and patterns of postoperative recurrence. Amini N, Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC,.. Ann Surg Oncol. 2016;23(1):126-133.

Significance of intravenous thrombus in the management of adrenocortical carcinoma: prognosis and surgical implications [abstract]. Ahmed S, Tran T, Levine EA, Weber S, Salem AI, Postlewait LM, Maithel SK, Wang T, Hatzaras I, Shenoy R, Phay J, Shirley L, Fields RC, Jin L, Pawlik TM, Prescott J, Sicklick J, Gad S, Yopp A, Mansour J, Duh Q, Seiser N, Solorzano CC, Kiernan CM,.. Ann Surg Oncol. 2016;23(Suppl 1):S101.

Multi-institution review of the role of cytoreductive surgery and heated intraperitoneal chemotherapy in metastatic gastric adenocarcinoma in the U.S. [abstract]. Enomoto LM, Choudry MA, Pakrafter S, Magge D, Votanopoulos K, Levine EA, Turaga K, Pameijer C, Wong J.. Ann Surg Oncol. 2016;23(Suppl 1):S22.

Lymphadenectomy for adrenocortical carcinoma: is there a therapeutic benefit? [abstract]. Gerry J, Postlewait LM, Maithel S, Prescott J, Wang T, Glenn JA, Phay J, Keplinger K, Fields RC, Jin L, Weber S, Salem AI, Sicklick J, Gad S, Yopp A, Mansour J, Duh Q, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos K, Levine EA, Hatzaras I, Shenoy R.. Ann Surg Oncol. 2016;23(Suppl 1):S100.

Adjuvant radiation therapy in patients undergoing curative intent resection for adrenocortical carcinoma: a multi-institutional experience [abstract]. Hatzaras I, Rao R, Tran TB, Postlewait LM, Maithel SK, Prescott J, Pawlik TM, Wang T, Phay J, Fields RC, Jin L, Weber S, Salem AI, Sicklick J, Gad S, Yopp A, Mansour J, Duh Q, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos K, Levine EA, Newman E,.. Ann Surg Oncol. 2016;23(Suppl 1):S99.

Stage-specific prognostic effect of race in patients with resectable gastric adenocarcinoma: an 8-institution study of the US Gastric Cancer Collaborative. Wang A, Squires MH III, Melis M, Poultsides GA, Norton JA, Jin LX, Fields RC, Spolverato G, Pawlik TM, Votanopoulos KI, Levine EA, Schmidt C, Bloomston M, Cho CS, Weber S, Berman R, Pachter HL, Newman E, Staley CA, Maithel SK, Hatzaras I.. J Am Coll Surg. 2016;222(4):633-643.

Association of survival, postoperative morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using quality of life assessments [abstract]. Dodson RM, Mogal H, Russell G, Duckworth KE, Votanopoulos K, Shen P, Levine EA, McQuellon RP.. Ann Surg Oncol. 2016;23(Suppl 1):S35.

Prognostic molecular subtypes of low-grade cancer of the appendix. Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, Ruiz J, D'Agostino R, Shen P, Miller LD.. J Am Coll Surg. 2016;222(4):493-503.

Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes. Mogal H, Chouliaras K, Levine EA, Shen P, Votanopoulos KI.. J Gastrointest Oncol. 2016;7(1):129-142.

Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. Gastric Cancer Collaborative. Randle RW, Swords DS, Levine EA, Fino NF, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LX, Spolverato G, Schmidt C, Worhunsky D, Cho CS, Maithel SK, Votanopoulos KI.. J Surg Oncol. 2016;113(7):750-755.

Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine EA.. J Gastrointest Oncol. 2016;7(1):3-9.

Interaction of postoperative morbidity and receipt of adjuvant therapy on long-term survival after resection for gastric adenocarcinoma: results from the U.S. Gastric Cancer Collaborative. Jin LX, Sanford DE, Squires MH III, Moses LE, Yan Y, Poultsides GA, Votanopoulos KI, Weber SM, Bloomston M, Pawlik TM, Hawkins WG, Linehan DC, Schmidt C, Worhunsky DJ, Acher AW, Cardona K, Cho CS, Kooby DA, Levine EA, Winslow E, Saunders N,.. Ann Surg Oncol. 2016;23(8):2398-2408.

Readmission following gastric cancer resection: risk factors and survival. Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, Pawlik TM, Jin LX, Ejaz A, Kooby DA, Bloomston M, Worhunsky D, Levine EA, Saunders N, Winslow E, Cho CS, Leverson G, Maithel SK, Weber SM.. J Gastrointest Surg. 2016;20(7):1284-1294.

A histomorphologic grading system that predicts overall survival in diffuse malignant peritoneal mesothelioma with epithelioid subtype. Valente K, Blackham AU, Levine E, Russell G, Votanopoulos KI, Stewart JH, Shen P, Geisinger KR, Sirintrapun SJ.. Am J Surg Pathol. 2016;40(9):1243-1248.

Lymphadenectomy for adrenocortical carcinoma: is there a therapeutic benefit?. Gerry JM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn JA, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA,.. Ann Surg Oncol. 2016;23(Suppl 5):708-713.

Quality-of-life evaluation after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA.. Ann Surg Oncol. 2016;23(Suppl 5):772-783.

Actual 10-year survivors following resection of adrenocortical carcinoma. Tran TB, Postlewait LM, Maithel SK, Prescott JD, Wang TS, Glenn J, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Hatzaras I,.. J Surg Oncol. 2016;114(8):971-976.

The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: an introduction of the peritoneal surface disease severity score. Sleightholm R, Foster JM, Smith L, Ceelen W, Deraco M, Yildirim Y, Levine E, Munoz-Casares C, Glehen O, Patel A, Esquivel J.. J Surg Oncol. 2016;114(7):779-784.

Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Doud AN, Randle RW, Clark CJ, Levine EA, Swett KR, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2015;22(5):1645-1650.

Peritoneal surface disease with synchronous hepatic involvement treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Randle RW, Doud AN, Levine EA, Clark CJ, Swett KR, Shen P, Stewart JH, Votanopoulos KI.. Ann Surg Oncol. 2015;22(5):1634-1638.

Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. Votanopoulos KI, Russell G, Randle RW, Shen P, Stewart JH, Levine EA.. Ann Surg Oncol. 2015;22(4):1274-1279.

Factors associated with recurrence and survival in lymph node-negative gastric adenocarcinoma: a 7-institution study of the US Gastric Cancer Collaborative. Jin LX, Moses LE, Squires MH III, Poultsides GA, Votanopoulos K, Weber SM, Bloomston M, Pawlik TM, Hawkins WG, Linehan DC, Strasberg SM, Schmidt C, Worhunsky DJ, Acher AW, Cardona K, Cho CS, Kooby DA, Levine E, Winslow ER, Saunders ND,.. Ann Surg. 2015;262(6):999-1005.

Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Randle RW, Ahmed S, Levine EA, Fino NF, Swett KR, Stewart JH, Shen P, Votanopoulos KI.. J Surg Oncol. 2015;111(6):740-745.

Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM.. Ann Surg. 2015;262(6):991-998.

Can the risk of non-home discharge after resection of gastric adenocarcinoma be predicted: a seven-institution study of the US Gastric Cancer Collaborative. Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, Pawlik TM, Jin LX, Ejaz A, Kooby DA, Bloomston M, Worhunsky D, Levine EA, Saunders N, Winslow E, Cho CS, Meredith K, Leverson G, Maithel SK, Weber SM.. J Gastrointest Surg. 2015;19(2):207-216.

Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the US Gastric Cancer Collaborative. Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM.. Ann Surg Oncol. 2015;22(2):557-564.

Changing pattern in malignant mesothelioma survival. Faig J, Howard S, Levine EA, Casselman G, Hesdorffer M, Ohar JA.. Transl Oncol. 2015;8(1):35-39.

Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH IV, Shen P, Levine EA, Votanopoulos KI.. J Surg Res. 2015;196(2):229-234.

Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative. Squires MH III, Kooby DA, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Votanopoulos KI, Fields RC, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Levine EA, Jin LX, Cho CS, Bloomston M, Winslow ER, Russell MC, Cardona K, Staley CA, Maithel SK.. Ann Surg Oncol. 2015;22(4):1243-1251.

A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma. Kim Y, Spolverato G, Ejaz A, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Levine EA, Cho CS, Maithel SK, Pawlik TM.. Ann Surg Oncol. 2015;22(6):1828-1835.

Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. Bagante F, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI,.. J Surg Oncol. 2015;112(2):164-172.

Is linitis plastica a contraindication for surgical resection? A 7-institution study of the US Gastric Cancer Collaborative [abstract]. Blackham AU, Swords DS, Levine EA, Fitzgerald N, Squires MH, Poultsides GA, Fields RC, Bloomston M, Weber SM, Pawlik TM, Jin LDX, Spolverato G, Winslow E, Schmidt CR, Kooby DA, Worhunsky DJ, Saunders N, Cho CS, Maithel SK, Votanopoulos KI.. J Clin Oncol. 2015;33(3 Suppl):118.

An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: a seven-institution analysis of 837 patients from the U.S. Gastric Cancer Collaborative. Dann GC, Squires MH III, Postlewait LM, Kooby DA, Poultsides GA, Weber SM, Bloomston M, Fields RC, Pawlik TM, Votanopoulos KI, Schmidt CR, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Levine EA, Jin LX, Cho CS, Winslow ER, Russell MC,.. J Surg Oncol. 2015;112(2):195-202.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Oncology

Clinical Interests

Sarcoma, Gastrointestinal Tumors, Esophageal Cancer, Mesothelioma, Peritoneal Carcinomatosis, Esophageal Tumors, Melanoma, Breast Cancer
Edward A. Levine, M.D.

Edward A. Levine, M.D.

Core Director, Comprehensive Cancer Center
Director-At-Large, Comprehensive Cancer Center
Surgical Sciences-Oncology
Professor, Surgical Sciences-Oncology
Office of Women in Medicine and Science

Doctor Rating

4.7 out of 5

Edward A. Levine, M.D.302 Ratings
31 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
3.8



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/13/2017

good

2/21/2017

great

2/21/2017

Dr. Levine is very professional at all my appointments, schedules my return appointments in a timely manner and I am very pleased to have no cancer cells show on my six month follow up scan. He was a great oncology surgeon and my husband was very pleased with the updates from the surgical suite during the very detailed and length process of the surgery. I really cannot say enough great thing about Dr. Levine and have told everyone here in my town about how wonderful Wake Forest Medical Center has been during this process.

1/23/2017

I have full confidence in Dr. Levine and his team. He is compassionate, knowledgeable, and capable, and one of the few resources in this country who has the expertise to deal with my disease. It was very comforting and reassuring to meet with him and his team.

1/20/2017

so far all experiences have been great. Very pleased. #9. Excellent.

1/20/2017

*Dr Levine provides outstanding care. Very fortunate to be under his care.

1/9/2017

He is the best that is why I am coming down from Richmond to see him.

1/8/2017

Dr. Levine is nearly perfect!

1/7/2017

former employee so had opportunity to seal with provideder previously but first time meeting him good experience

12/27/2016

THIS PROVIDER IS EXCELLENT IN HIS SPECIALTY BUT ALSO HAS NO REGARD FOR PATIENTS TIME. 2 HOURS AND 45 MINUTES WITH ZERO COMMUNICATION FROM ANYONE IN CLINIC IS TOTALLY UNACCEPTABLE.

11/29/2016

Good followup visit after surgery one year ago. Results are good.

11/28/2016

Dr. LeVine instills confidence by his manner and and expertise. I am always happy to talk with and have been taken care of by Dr. LeVine.

11/17/2016

*Dr. Levine is an amazing physician.

10/27/2016

I have the utmost confidence in Dr. Levine. He's our "go to' guy.

10/25/2016

THE BEST

10/19/2016

Dr. Levine is tops in his field. I have already told many people about the excellent care I received from him and from WFBH.

9/20/2016

Doctor was great!

9/19/2016

Dr Levine is a very kind understanding doctor. Have great confidence in him.

9/12/2016

good

9/5/2016

5 star I was very pleased with everything

8/24/2016

Excellent.

8/18/2016

I feel I receive excellent care in every way. I have a lot of confidence I am receiving the best care possible. He is very friendly and easy to talk to about any concerns I have.

8/13/2016

okay

8/11/2016

Surgeon Levine is outstanding in all accounts.

8/9/2016

I was most impressed with the Comprehensive Cancer Center - doctors, nurses, and staff. They all helped make a difficult and scary experience much better. I was also impressed with the confidence and hopefulness they give by being so positive and energetic. Their compassion and caring concern was readily apparent.

8/9/2016

*Dr. Levine is "WONDERFUL" I'll miss him!!! I am in the "BEST" of care!!!

8/1/2016

I feel deeply grateful for *Dr. Levine's clinical expertise and wisdom. He is an excellent physician AND an excellent doctor.

7/28/2016

I've had Dr. Levine as my physician for 15 years. I won't go to anyone else.

7/6/2016

Dr. Levine is a very caring and ubunderstanding surgeon. His beside manner is wonderful and needed during and through out your treatment.

7/4/2016

*Dr. Levine saved my life, he saves 100s of lives yearly but always treats me like he saw me just last week. I cannot say enough good things about him and WFB as a whole.

6/21/2016

good

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Five Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.